This review discusses the therapeutic drugs that act on the pregnant uterus. These may be thought of as modifiers of endogenous uterine physiological pathways and include those agents acting upon the oxytocin receptor, prostaglandin pathways, progesterone receptors, ß-adrenergic receptor, calcium channels and via nitric oxide. Agents that are currently used for the induction of labour, termination of pregnancy, augmentation of labour and tocolytics are discussed.
No full text is available. To read the body of this article, please view the PDF online.
aImperial College Parturition Research Group, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK
bInstitute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Imperial College Parturition Research Group, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK
cInstitute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK, Imperial College Parturition Research Group, Institute of Reproductive and Developmental Biology, Queen Charlotte's and St Mary's Hospitals, London, UK
f1 Correspondence to: BAJ. Tel.: +44(0)207 594 2137; Email: basjones@hotmail.com
ABSTRACT